As­traZeneca sub­sidiary to sell its Ban­ga­lore site, to hunt for ex­ter­nal man­u­fac­tur­er 

As­traZeneca’s In­dia sub­sidiary is sell­ing its on­ly man­u­fac­tur­ing site in Ban­ga­lore as part of an on­go­ing strate­gic re­view of its man­u­fac­tur­ing and sup­ply net­work, ac­cord­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.